[Webinar] Understanding the State Prescription Drug Affordability Board Landscape in 2024

February 27th, 10:00 am - 11:00 am PT
Manatt, Phelps & Phillips, LLP
Contact

Manatt, Phelps & Phillips, LLP

February 27th, 2024
10:00 AM - 11:00 AM PT

Featuring Guest Speakers From PhRMA and Harvard Medical School

Several states are considering or have enacted legislation to create prescription drug affordability boards (PDABs). Although their powers vary by state, PDABs are generally charged with assessing the affordability of prescription drugs and developing recommendations to reduce spending; negotiating Medicaid supplemental rebates with manufacturers; and/or setting upper payment limits (UPLs), which seek to limit the amount payers, providers, pharmacies and patients can pay for prescription drugs. In 2024, Colorado’s PDAB—the first in the country to begin conducting affordability reviews—is poised to determine whether to impose a UPL, and PDABs in other states are following Colorado’s lead. The ability of PDABs to implement UPLs, however, faces several operational and legal challenges.

In a new webinar, Manatt Health and thought leaders from PhRMA and Harvard Medical School will examine the current PDAB landscape and the ways it could reshape the pharmaceutical supply chain. Click here to register for the free webinar.

Key questions the program will answer include:

  • Which states have PDABs—and what is the status of PDAB activities in each state?
  • How does PDABs’ power differ among states?
  • How can PDABs attempt to implement a UPL?
  • How could a UPL impact the pharmaceutical supply chain?
  • What potential legal objections might be raised against UPLs—and how have these arguments fared in the past?

Even if you can’t make our live session on February 27, click here to register for the free webinar now, and you’ll receive a link to view the program on demand.

Speakers

  • Michael Kolber, Partner, Manatt Health
  • Jonathan DiBello, Manager, Manatt Health
  • Benjamin N. Rome, M.D., M.P.H., Instructor in Medicine, Harvard Medical School and Division of Pharmacology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
  • Leslie Wood, Regional Vice President—State Policy, PhRMA

If you would like to receive an audio transcript of this webinar due to accessibility issues, please email us at webinars@manatt.com.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Manatt, Phelps & Phillips, LLP | Attorney Advertising

PRESENTED BY:

Manatt, Phelps & Phillips, LLP
Contact
more
less

Manatt, Phelps & Phillips, LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide